Fosaprepitant versus aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: a multicenter, randomized, double-blind, double-simulated, positive-controlled phase III trial

BACKGROUND: To establish the role of antiemetic therapy with neurokinin-1 (NK-1) receptor antagonists (RAs) in Chinese patients associated with cisplatin-base chemotherapy regimens, this study evaluated the efficacy and safety of single-dose intravenous fosaprepitant-based triple antiemetic regimen t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhonghan, Yang, Yunpeng, Lu, Ping, Li, Xiaoqin, Chang, Jianhua, Zheng, Rongsheng, Zhou, Lei, Chen, Shaoshui, Chen, Xiaopin, Ren, Biyong, Gu, Wei, Jiang, Xiaodong, Peng, Jiyong, Huang, Miaolong, Feng, Guosheng, Shen, Peng, Zhang, Qingyuan, Zhang, Baihong, Huang, Yan, He, Jingdong, Chen, Yinglan, Cao, Jingxu, Wang, Hong, Li, Wei, Wan, Huiping, Nan, Kejun, Liao, Zijun, Zhang, Cuiying, Lin, Zhong, Zhong, Diansheng, Xu, Qing, Liu, Hailong, Sun, Tao, Deng, Yanming, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154406/
https://www.ncbi.nlm.nih.gov/pubmed/32309381
http://dx.doi.org/10.21037/atm.2019.12.158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154406/
https://www.ncbi.nlm.nih.gov/pubmed/32309381
http://dx.doi.org/10.21037/atm.2019.12.158

Ejemplares similares